Diagnosis of antiphospholipid syndrome. Bertolaccini ML, Khamashta MA, Hughes GR. Nat Clin Pract Rheumatol. 2005 Nov;1(1):40-6. – doi:10.1038/ncprheum0017

more Information

Antiphospholipid antibody tests: spreading the net. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA Ann Rheum Dis 2005;64:1639–1643. doi: 10.1136/ard.2005.035824

more Information

The antiphospholipid syndrome. Fischer MJ, Rauch J, Levine JS. Semin Nephrol. 2007 Jan;27(1):35-46. – doi:10.1016/j.semnephrol.2006.09.006

more Information

How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Garcia DA, Khamashta MA, Crowther MA. Blood, 2007 Nov 1;110(9):3122-7. – doi:10.1182/blood-2006-10-041814

more Information

Mechanisms of disease: antiphospholipid antibodies- from clinical association to pathologic mechanism. de Laat B, Mertens K, de Groot PG. Nat Clin Pract Rheumatol. 2008 Apr;4(4):192-9. – doi:10.1038/ncprheum0740

more Information

Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke. Kahles T, Humpich M, Steinmetz H, Sitzer M, Lindhoff-Last E. Rheumatology, 2005;44:1161-5. – doi:10.1093/rheumatology/keh698

more Information

Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2- GPI) antibodies: importance of IgA isotype. Lakos G, Kiss E, Regëczy N, Tarján P, Soltész P, Zeher M, Bodolay E, Szakony S, Sipka S, Szegedi G. Clin Exp Immunol. 1999;117:574-9.

more Information

Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Loizou S, Singh S, Wypkema E, Asherson RA. Ann Rheum Dis. 2003;62:1106-11. – doi: 10.1136/ard.62.11.1106

more Information

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. J Thromb Haemost. 2006 Feb;4(2):295-306.

more Information

Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2- glycoprotein I and anti-phosphatidylserine/prothrombin antibodies – Co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y. Thromb Haemost. 2004 May;91(5):967-76. – doi:10.1160/TH03-10-0608

more Information

Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases. Swadzba J, Iwaniec T, Szczeklik A, Musia J. J Thromb Haemost. 2007 Sep;5(9):1883-9.

more Information

Cookies erleichtern die Bereitstellung unserer Dienste. Mit der Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies verwenden.
Weitere Informationen Ok